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Summary Patients with hematological malignancies are susceptible to unusual infections,
because of the use of broad-spectrum anti-infective agents, invasive procedures, and other
immunocompromising procedures and medications. Gordonia polyisoprenivorans, a ubiquitous
environmental aerobic actinomycete belonging to the family of Gordoniaceae in the order
Actinomycetales, is a very rare cause of bacteremia in these patients. We report the first case
of pneumonia with associated bacteremia due to this organism, which was initially described in
1999 as a rubber-degrading bacterium following isolation from stagnant water inside a deterio-
rated automobile tire. We believe that hematologically immunocompromised patients on broad-
spectrum antibiotics and with long-term central catheters select the possibility of infection with
G. polyisoprenivorans. These infections can be prevented by handling catheters under aseptic
conditions. We propose that blood cultures of persistently febrile neutropenic patients should be
incubated for at least 4 weeks. Being a rare infection, there are no data available on treatment
other than early removal of the foreign bodies.
# 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Patients with hematological malignancies are susceptible to
unusual infections, because of the use of broad-spectrum
anti-infective agents, invasive procedures, and other immu-
nocompromising procedures and medications. Gordonia
polyisoprenivorans is a very rare cause of bacteremia in
these patients. We report the first case of pneumonia with
associated bacteremia due to G. polyisoprenivorans.* Corresponding author. Tel.: +1 732 668 3793.
E-mail address: mohit_gupta13@yahoo.com (M. Gupta).
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A 17-year-old woman with undifferentiated myeloblastic
leukemia (AML M1 type) was 5 weeks post-cytarabine and
mitoxantrone intensification therapy. She presented to the
hospital with 4 days of fever, rhinorrhea, and productive
cough. She was already under treatment with azithromycin
and ciprofloxacin for a presumed Rhodococcus equi bacter-
emia diagnosed 3 weeks earlier. At this time, her Broviac
catheter was replaced and a new Broviac was inserted. On
examination, no source of infection was found. Laboratory
work-up was significant for a white cell count of 0.3  109/l.Published by Elsevier Ltd. All rights reserved.
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lung; this was radiologically confirmed on computed tomo-
graphy (CT) scan, which also revealed multiple scattered
subsegmental nodules. This confirmed a lobar pneumonia
probably due to bacteria or atypical organisms. She was
started on vancomycin and ceftazidime in addition to her
ciprofloxacin and azithromycin. Ambisome was also added
for Aspergillus coverage. In hospital, the patient continued
to be symptomatic and thus a bronchoscopy was done and
caspofungin was started for additional fungal coverage.
However, the bronchial washings remained negative for
bacteria, fungus, acid-fast bacilli, Legionella, virus, and
malignant cells. An echocardiogram was done, which ruled
out any intracardiac vegetations. Since the patient contin-
ued to be symptomatic, a bone marrow aspirate and biopsy
was done to rule out recurrence of leukemia and showed only
hypocellular marrow. The cultures belonging to this immu-
nocompromised host were preserved for 4 weeks as per our
institution’s policy. They continued to be negative until 4
weeks after admissionwhen 2/2 blood cultures grew aGram-
positive non-acid-fast organism identified by the Centers for
Disease Control and Prevention (CDC) to be G. polyisopre-
nivorans. The CDC identified it to be a Gram-positive pleo-
morphic actinomycete, which was non-acid-fast, oxidase-
negative, catalase-positive, and turned greenish brown on
rabbit blood agar. This was confirmed to be G. polyisopre-
nivorans on the basis of sequencing of the 16S rRNA gene.
However, the CDC could not provide any susceptibility
results.
Discussion
Gordonia polyisoprenivorans is a ubiquitous environmental
aerobic actinomycete belonging to the family of Gordonia-
ceae in the order Actinomycetales. All of the 21 identified
species are Gram-positive, catalase-positive, weakly acid-
fast, thin beaded coccobacilli.1 G. polyisoprenivorans was
first described in 1999 as a rubber-degrading bacterium
following isolation from stagnant water inside a deteriorated
automobile tire.2 It is able to form biofilms due to the
presence of mycolic acids and biosurfactants. Biofilms enable
this organism to evade host defenses and cause persistent
infections despite the use of prolonged antibiotics. Degrada-tion of rubber, a component of intravascular devices, also
contributes to its pathogenesis.1
An extensive literature review only identified two case
reports of bacteremia and no cases of pneumonia due to this
unusual organism. This organism was first described in a 24-
year-old bone marrow recipient who became febrile after
manipulation of her Hickman catheter, with G. polyisopre-
nivorans grown in a single blood culture.3 In 2006, Verma
et al. described a 78-year-old male with a past medical
history of Osler—Weber— Rendu and myelodysplastic syn-
drome with pancytopenia, who developed endocarditis due
to this organism secondary to long-term catheter use.1 This is
similar to our patient, who, although she did not have a
relapse of leukemia, was neutropenic and had a central
venous catheter. We believe that hematologically immuno-
compromised patients on broad-spectrum antibiotics and
with long-term central catheters select the possibility of
infection with G. polyisoprenivorans.
To the best of our knowledge and from our literature
search, this is the first case of pneumonia with associated
bacteremia due to this organism. These infections can be
prevented by handling catheters under aseptic conditions.
We propose that blood cultures of persistently febrile
neutropenic patients should be incubated for at least 4
weeks. Being a rare infection, there are no data available
on treatment other than early removal of the foreign
bodies.
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